tirzepatide breast cancer 🚨Scientists found an FDA-approved druge that shrinks tumors! In an unexpected and promising discovery, researchers have found that tirzepatide, a drug approved for diabetes and weight loss under the names Cancer: ENDO 2025 | Tirzepatide

In addition to the benefits mentioned above, it is enriched with AstriGin, a patented natural compound that enhances the absorption of nutrients, including glutathione, and also supports intestinal health and immune functions.

Healthcare professionals submitted 149 reports in 2025 involving patients who had used injectable weight-loss drugs, up from 76 reports in 2024, according to data from the Dutch National Poisons Information Centre, known as NVIC, at University Medical Center Utrecht

Prescriptions are only provided if medically appropriate after consultation

Because convenience can work in both directions

The HCLF group is burning much less fat but also storing much less fat